Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
JP Stock MarketDetailed Quotes
4588 Oncolys BioPharma
- 506
- -100-16.50%
20min DelayMarket Closed Dec 20 15:30 JST
12.61BMarket Cap-4.65P/E (Static)
540High506Low3.38MVolume533Open606Pre Close1.74BTurnover91852wk High14.88%Turnover Ratio24.92MShares42052wk Low-95.72EPS TTM11.48BFloat Cap4410Historical HighLossP/E (Static)22.69MShs Float401Historical Low-108.92EPS LYR5.61%Amplitude--Dividend TTM8.08P/B100Lot Size--Div YieldTTM
About Oncolys BioPharma Company
Oncolys BioPharma Inc develops pharmaceutical products. The company is engaged in research and development of oncolytic viruses, drugs for serious infectious diseases, molecular targeted anti-cancer drugs, and tumor diagnostic agents.
Company Profile
Symbol4588
Company NameOncolys BioPharma
Founded2004-03-18
MarketTSE Growth
Fiscal Year Ends12-31
Address4-1-28 Toranomon Toranomon Towers Office
Zip Code105-0001
Phone03-5472-1578
Websitewww.oncolys.com
Company Executives
- Name
- Position
- Salary
- Yasuo Urata
- President and Chief Executive Officer, Research and Development and CMC
- --
- Yasunari Katagihara
- Director of Business Development and Risk Management
- --
- Naoko Iino
- Independent Director
- --
- Yasushi Saitou
- Independent Director
- --